We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

February 27, 2020

News You Need - 3 Big Little Things from HealthXL

Commentary
Chandana Fitzgerald
&

It’s time for your monthly digital health news dose. We have looked back at three of the most noteworthy pieces of news from the last month and distilled what they mean for the industry and the key takeaways you should have on your radar. Interested in getting beyond the headlines? We’ve included three industry experts who can help you get behind these stories - just let us know if you’d like us to make the introduction!


1. Skin lesion detection apps not as reliable despite CE mark?

Story snapshot: A review in the BMJ identified nine eligible studies that evaluated apps for risk stratification of skin lesions, and showed variable and unreliable test accuracy for six different apps.

Why is it notable? Evidence and regulation in question. 

Industry Implications - Push for education and clarity. 

Letter to the Editor

In response to the above story you just read, we've received a note from our friends at Skin Vision with their take on the same. There's always two sides to every story, so HealthXL wishes to provide them with an avenue for their perspective.

Response from Erik de Heus, CEO Skin Vision:

‘’SkinVision would like to confirm that, as per published studies and regulators approval, the SkinVision Service is safe and effective, and has so far already helped to identify thousands of cases of skin cancer.

Specifically:

  • SkinVision can detect 95% of skin cancer cases https://onlinelibrary.wiley.com/doi/10.1111/jdv.15935. The sensitivity of general practitioners ranges from 61% and 66%, while the sensitivity of dermatologists is between 75% and 92%.
  • SkinVision goes beyond legal and regulatory minimum requirements - for example by having achieved voluntary independent certifications (ISO 13485, ISO 27001).
  • The BMJ article does not consider key factors, and specifically: ignores recent studies with positive results for SkinVision; does not consider the benefits of the device but only risks; provides potentially misleading information on SkinVision’s compliance status, and public health impact.

SkinVision’s official reply to the BMJ can be found here: BMJ.com, and additional information can be found on our website www.skinvision.com‘’

Erik de Heus
Erik de Heus
Chief Executive Officer
SkinVision

Erik, as the CEO of SkinVision, which aspires to increase awareness for the risk of skin cancer, is best positioned to address questions about their safety and efficacy.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

2: Babylon Health and physician from the NHS tussle over triage chatbot’s safety.

Story snapshot: On the note of diagnostic bots, and two sides to any story, Babylon Health gave in this week and reacted to provocation from their long-time Twitter critic, Dr David Watkins (i.e @DrMurphy11). In what has now become a media war, Babylon is defending it's algorithms and DrMurphy11 is challenging their validity and accuracy. 

Why is it notable? Set clear expectations. 

Keith Grimes
Keith Grimes
Clinical Innovation Director
Babylon Health

Dr Keith Grimes leads some of the efforts to develop new approaches and techniques for delivering healthcare. He looks into AI safety, AI regulation and governance.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

3: Big Tech and WHO meet to stop COVID-19 infodemic

Story snapshot: As the world wide web is becoming increasingly awash with misinformation about the coronavirus (COVID-19), the modern gatekeepers of information - Facebook, Google, Amazon & Co. - met last week to discuss how to halt the spread of fake news about the disease.

Why is it notable? Nip it in the bud. 

Industry Implications - Social media is a boon and a bane. 

Rob Grenfell
Rob Grenfell
Director - Health and Biosecurity
CSIRO

Dr Rob Grenfell is a Public Health Physician and former Senior Medical Advisor at the Department of Health Victoria. He is currently actively involved in managing and containing the Coronavirus outbreak in Australia, and is also spearheading efforts to trial new vaccines and treatments for the same.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Ready to read more? HealthXL members can access the full peak of the report on the HealthXL Community Hub.

Not yet a member of HealthXL? Download your 11 page snapshot of the report.

Download your 11 page snapshot

Connect with peers and share insights

Don't miss out on the discussion of the latest insights and reports on digital health. Meet with peers and take a deep dive for 75 minutes. Unlike at webinars, you can freely exchange experiences and insights to solve challenges and design the future of DTx.

Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Masterclass: How to Navigate the NHS Digital Technology Assessment Criteria and NICE evidence guidelines

1st February @ 10AM GMT / 6PM AWST

Are you trying to increase adoption and use of your Digital Health solution across the UK's National Health Service? Join your peers in this meeting as they deep dive into this topic. Apply now to secure your place as seats are limited.

Featuring
Richard Bunney
Richard Bunney
Director, Cuniculo Ltd
Featuring
Richard Bunney
Richard Bunney
Director, Cuniculo Ltd
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Masterclass: Endpoints and Control Arms in Trials for DTx

15th February @ 10:45AM EDT

Proving clinical efficacy is one of the biggest challenges for DTx companies. Apply now to join HealthXL in this session to dive deeper into this topic with leaders in this field.

Featuring
Acacia Parks
Acacia Parks
Chief Science Officer, Twill
Featuring
Acacia Parks
Acacia Parks
Chief Science Officer, Twill
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

The Role of the Consumer Experience in DTx

15th February @ 10:45AM EDT

As technology advances in all sectors (e.g. fintech, entertainment, etc), consumer behaviour changes and the expectations on user experience are higher than before. Apply now to secure your place in this meeting where you will dive deeper into this topic with your peers.

Featuring
Lee Shapiro
Lee Shapiro
Managing Partner, 7wireVentures
Featuring
Lee Shapiro
Lee Shapiro
Managing Partner, 7wireVentures
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Masterclass: Incorporating Extended Reality (XR) in Physician's’ Daily Work

28th February @ 10:45AM EDT

The healthcare industry is undergoing a digital transformation and extended reality (XR) technologies such as virtual reality (VR) and augmented reality (AR) are expected to play a significant role in this change in the next few years. Apply now to join this Masterclass led by Nemanja Kovačev, MedTech Expert at HTEC Group.

Featuring
Nemanja Kovačev
Nemanja Kovačev
MedTech Expert, HTEC Group
Featuring
Nemanja Kovačev
Nemanja Kovačev
MedTech Expert, HTEC Group

Are you a HealthXL Member? See the Full Report Here

Non-HealthXL Member? You can purchase the report HERE

HealthXL Digital Health Meetings

Want to join the discussion now?

Join our Digital Health Meetings and take a deep dive for 75 minutes into topics like digital therapeutics, patient support, telehealth, clinical trials, dermatology and many more. These Meetings are not regular webinars: No audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And with a free account on our Community Hub, you stay connected and up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

Digital Health in Oncology
31st January @ 10:45AM EDT

Are Hospitals the Right Partner for Digital Health Companies in Oncology?

Digital health in oncology is still a very raw and undefined practice with companies still searching for a best approach to put these solutions into the patients' hands. Join this peer-to-peer conversation to deep dive into this discussion.

Eoin Tabb
Featuring
Eoin Tabb
A/ Chief II Pharmacist, Cancer Services, HSE
Clinical Trials Innovation
1st February @ 11AM EDT

HealthXL Webinar: The Potential of AI in Drug Discovery

The drug discovery process has traditionally been costly and very time-consuming. Join this Webinar to deep dive into this topic with senior leaders in this area.

Armen Vidian
Featuring
Armen Vidian
Digital Health Venture Capitalist
Digital Therapeutics (DTx)
1st February @ 10AM GMT / 6PM AWST

Masterclass: How to Navigate the NHS Digital Technology Assessment Criteria and NICE evidence guidelines

Are you trying to increase adoption and use of your Digital Health solution across the UK's National Health Service? Join your peers in this meeting as they deep dive into this topic. Apply now to secure your place as seats are limited.

Richard Bunney
Featuring
Richard Bunney
Director, Cuniculo Ltd
Telemedicine & Virtual Care Delivery
2nd February @ 10:45AM EDT

Masterclass: How to Make Value-Based Health Care (VBHC) work with Digital Health?

Would you like to learn more about value-based health care models (VBHC) and the interplay between these systems and digital health solutions? Join HealthXL in this Masterclass led by Matt Hickey to deep dive into this topic. Seats are limited so apply now to secure your place.

Matt Hickey
Featuring
Matt Hickey
CEO, The Health Value Alliance

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.